Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bioactive factors for bone tissue engineering.

S D Boden1

  • 1Department of Orthopaedic Surgery, Emory University School of Medicine, Atlanta, GA 30033, USA.

Clinical Orthopaedics and Related Research
|November 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AOA Critical Issues Symposium: So, You Want to Be a Department Leader: Essentials for Success.

The Journal of bone and joint surgery. American volume·2024
Same author

Spine fusion by gene therapy.

Gene therapy·2004
Same author

Demineralized bone matrix, bone morphogenetic proteins, and animal models of spine fusion: an overview.

European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2001
Same author

Do the intervertebral disc cells respond to different levels of hydrostatic pressure?

Clinical biomechanics (Bristol, Avon)·2001
Same author

Bone-graft substitutes: facts, fictions, and applications.

The Journal of bone and joint surgery. American volume·2001
Same author

Anterior lumbar interbody fusion using a barbell-shaped cage: a biomechanical comparison.

Journal of spinal disorders·2001
Same journal

Impact Microindentation Evaluates Bone Strength, Bone Quality, and Fracture Susceptibility Across Skeletal Sites: A Cadaver Study.

Clinical orthopaedics and related research·2026
Same journal

What Is the Effect of Robot Reduction in Displaced Pelvic Fractures? A Multicenter Randomized Clinical Trial.

Clinical orthopaedics and related research·2026
Same journal

CORR Insights®: Acute or Delayed TKA for Tibial Plateau Fracture? An Observational Study From the Swedish Arthroplasty Register.

Clinical orthopaedics and related research·2026
Same journal

Reply to the Letter to the Editor: Guest Editorial: Recalling a Recall.

Clinical orthopaedics and related research·2026
Same journal

Radial Head Fractures Cluster in the Anterolateral and Anteromedial Quadrants and Do Not Correlate With Coronoid Fracture Types.

Clinical orthopaedics and related research·2026
Same journal

Reduced Cerebellar Activation With Eyes Closed Is Associated With Delayed Peroneal Reaction Time in Patients With Chronic Ankle Instability.

Clinical orthopaedics and related research·2026
See all related articles

Bone tissue engineering is revolutionizing orthopaedic surgery, utilizing bioactive bone growth factors. Key strategies include growth factor extraction, recombinant protein synthesis, and gene therapy for enhanced bone regeneration.

Area of Science:

  • Orthopaedic surgery
  • Biomaterials science
  • Regenerative medicine

Background:

  • Orthopaedic surgery is shifting from traditional bone grafting to advanced bone tissue engineering.
  • Bioactive bone growth factors are crucial for the success of bone tissue engineering applications.

Purpose of the Study:

  • To review the primary strategies for employing bioactive factors in bone tissue engineering.
  • To examine preclinical and clinical results of specific bone growth factors.
  • To identify barriers to the clinical use of bone tissue engineering.

Main Methods:

  • Review of three main strategies: growth factor extraction/purification, recombinant protein synthesis, and gene therapy.
  • Evaluation of clinical trial data for bone morphogenetic protein-2 (BMP-2), bone morphogenetic protein-7 (BMP-7/OP-1), and NeOsteo bovine bone protein extract.

Related Experiment Videos

  • Analysis of obstacles hindering clinical implementation.

    • Main Results:

    • Bone morphogenetic proteins (e.g., BMP-2, BMP-7) show promise in preclinical and early clinical settings.
    • Different methods of delivering bioactive factors have varying degrees of success.
    • Clinical translation faces challenges including regulatory hurdles and cost-effectiveness.

    Conclusions:

    • Bioactive factors are central to the advancement of bone tissue engineering.
    • Further research and development are needed to overcome clinical implementation obstacles.
    • Bone tissue engineering holds significant potential to improve orthopaedic patient outcomes.